<code id='8AAEE13692'></code><style id='8AAEE13692'></style>
    • <acronym id='8AAEE13692'></acronym>
      <center id='8AAEE13692'><center id='8AAEE13692'><tfoot id='8AAEE13692'></tfoot></center><abbr id='8AAEE13692'><dir id='8AAEE13692'><tfoot id='8AAEE13692'></tfoot><noframes id='8AAEE13692'>

    • <optgroup id='8AAEE13692'><strike id='8AAEE13692'><sup id='8AAEE13692'></sup></strike><code id='8AAEE13692'></code></optgroup>
        1. <b id='8AAEE13692'><label id='8AAEE13692'><select id='8AAEE13692'><dt id='8AAEE13692'><span id='8AAEE13692'></span></dt></select></label></b><u id='8AAEE13692'></u>
          <i id='8AAEE13692'><strike id='8AAEE13692'><tt id='8AAEE13692'><pre id='8AAEE13692'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:16
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          Immune cells and nerve overgrowth may explain recurring UTI pain
          Immune cells and nerve overgrowth may explain recurring UTI pain

          AmastcellAdobeEachyear,morethan400millionurinarytractinfectionsoccurinpeoplearoundtheglobe.Andresear

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Streamlined flu vaccines recommended by FDA advisory panel

          AfluvaccinesyringerestsonatableatavaccinationclinicinLakewood,Calif.MarioTama/GettyImagesWhenAmerica